ACTRI Day of Translational Science Inspires the New Generation of Translational Researchers

DOTS

During the reception in the ACTRI building lobby are (from left): ACTRI Director Gary S. Firestein, MD; Day of Translational Science presenters Christina Holub, PhD and Camille Nebeker, EdD; and Day of Translational Science leaders Colin Depp, PhD and Paul Mills, PhD.

January 24, 2017

Inspiring research talks by J. Craig Venter and five translational scientists supported by the Altman Clinical and Translational Research Institute (ACTRI) marked the ACTRI Day of Translational Science on January 18. The afternoon event at the ACTRI building drew more than 100 UC San Diego researchers and concluded with a reception and poster session featuring research trainees from the ACTRI TL1 program. ACTRI clinic, community engagement, education and laboratory staff were also on hand at the reception to discuss resources available to researchers.

“One of best ways to inspire new generations of translational scientists is by highlighting the work of young researchers we have supported through our ACTRI education and pilot project programs,” said Paul Mills, PhD, who provided opening remarks and introduced the presenters for the first portion of the day’s program. The mini-presentations focused on studies ranging from Kawasaki disease to Pacific Islander fitness and health, and from smart-phone technology for monitoring cystic fibrosis to minimizing radiation damage to normal brain tissue and cognitive function in brain tumor patients. Mills is on the ACTRI Executive Committee and was one of the day’s organizers.

ACTRI Director Gary S. Firestein, MD, introduced Venter, who was the inaugural ACTRI seminar series speaker in the new building and keynote for the Day of Translational Science. “I’m very pleased to introduce Dr. Venter, one of the leading scientists of the 21st century – and I would also say of the 20th century – for his numerous invaluable contributions to genomic research.” Venter, a pioneer in sequencing the human genome, is Co-Founder and Executive Chairman of Human Longevity, Inc.; Co-Founder, Chairman, and Co-Chief Scientific Officer of Synthetic Genomics, Inc.; and Founder, Chairman, and CEO of the J. Craig Venter Institute. In his talk, “From Designing Life to Prolonging Healthy Life,” Venter discussed human genomics and the future of medicine, and the quest to transform medicine from reactive to proactive and preventative. Human Longevity, Inc. has sequenced more than 40,000 genomes.

View ACTRI Day of Translational Science Keynote Speaker

J. Craig Venter
From Designing Life to Prolonging Healthy Life
UCTV: UC Wellbeing Channel

View ACTRI Day of Translational Science Mini-Presentations

Jona Hattangadi-Gluth, MD –
Neuroimaging of Radiation-Induced Cognitive Change

Drew Hall, PhD
Smartphone-Based Home Monitoring of Pulmonary Exacerbations in Cystic Fibrosis

Christina Holub, PhD, MPH, Camille Nebeker, EdD, MS and Siaosi Veimau
Increasing Physical Activity Through a Culturally Tailored, Community-led Intervention Among Pacific Islanders: The Rawmana Fitness Pilot Study

Adriana Tremoulet, MD
Treatment Response and Sialic Acid Modification of IgG in Patients with Kawasaki Disease

Read the San Diego Union-Tribune article, “Center hopes to speed health advances from lab to patients” and view video clips of presenters.

DOTS

Research training students supported by an ACTRI education program called TL1 presented posters on their research during the ACTRI Day of Translational Science. They are (from left): Sirena Louie (Pharm); Sama Alpatty (Pharm); Paul Riviere (Med); Keenan Onodera (Med); Shawn Kim (Med); Aaron Bradshaw (Med); Victoria Wu (Med); and Lu Wu (Med) with ACTRI Education Manager Jill Dumbauld, MPH, and ACTRI Education Director Colin Depp, PhD.